MUC1 and prostate adenocarcinoma: There are 62.5% (n=5) of patients with prostatic adenocarcinoma in grade 6 showing positive overexpression of EMA protein, 66.7% (n=10) with prostatic adenocarcinoma in grade 7 showing positive overexpression of EMA protein and 88.2% (n=15) with prostatic adenocarcinoma in grade 7–10 showing positive overexpression of EMA protein.